Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:46:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details and location information for the study, replacing the previous version with new content in the Contacts and Locations section.
    Difference
    4%
    Check dated 2024-12-07T16:21:52.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several key genetics-related pages, including those on breast cancer and type 2 diabetes, have been removed from MedlinePlus, indicating a significant reduction in available resources on these conditions.
    Difference
    5%
    Check dated 2024-11-23T04:44:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    New resources related to genetics and specific conditions like breast cancer and type 2 diabetes have been added, along with links to major health organizations.
    Difference
    0.6%
    Check dated 2024-11-15T23:53:34.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.
    Difference
    5%
    Check dated 2024-11-08T18:27:04.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T10:52:32.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.